Variant report
Variant | esv3693332 |
---|---|
Chromosome Location | chr2:78857870-78870453 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs186808527 | chr2:78861222-78861223 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs141239718 | chr2:78861264-78861265 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs576265881 | chr2:78861295-78861296 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs79514068 | chr2:78861296-78861297 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs191999689 | chr2:78861308-78861309 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs146948536 | chr2:78861342-78861343 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs183366483 | chr2:78861411-78861412 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs137930697 | chr2:78861433-78861434 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs189221000 | chr2:78861434-78861435 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs192518704 | chr2:78861438-78861439 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs575202732 | chr2:78861443-78861444 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs555554300 | chr2:78861466-78861467 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs544031764 | chr2:78861489-78861490 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs116638111 | chr2:78861490-78861491 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs538982121 | chr2:78861553-78861554 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs544909730 | chr2:78861598-78861599 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs72917681 | chr2:78861610-78861611 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs574011312 | chr2:78861611-78861612 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs368894489 | chr2:78861635-78861636 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs545058480 | chr2:78861699-78861700 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs368229461 | chr2:78861706-78861707 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs564805376 | chr2:78861719-78861720 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs374930540 | chr2:78869024-78869025 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs182825401 | chr2:78869031-78869032 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs567394755 | chr2:78869034-78869035 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs529848607 | chr2:78869073-78869074 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs72917688 | chr2:78869090-78869091 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs563851178 | chr2:78869111-78869112 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs187446084 | chr2:78869123-78869124 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs115651043 | chr2:78869124-78869125 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs552573855 | chr2:78869193-78869194 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs200785615 | chr2:78869212-78869213 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs376052227 | chr2:78869229-78869230 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs369539167 | chr2:78869254-78869255 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs534985707 | chr2:78869285-78869286 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs192240353 | chr2:78869301-78869302 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs568726101 | chr2:78869310-78869311 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs148708403 | chr2:78869322-78869323 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs557265665 | chr2:78869385-78869386 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs576123374 | chr2:78869387-78869388 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs538335150 | chr2:78869460-78869461 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs79962411 | chr2:78869471-78869472 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs28575898 | chr2:78869476-78869477 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs571424721 | chr2:78869501-78869502 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs540583523 | chr2:78869510-78869511 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs560851523 | chr2:78869513-78869514 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs574387709 | chr2:78869529-78869530 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs184303417 | chr2:78869583-78869584 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs563320421 | chr2:78869600-78869601 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs532665414 | chr2:78869640-78869641 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Lung cancer | 18438408 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Mental retardation | 17124404 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Cancer | 17440070 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Breast cancer | 16272173 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:78861200-78861600 | Enhancers | Brain Germinal Matrix | brain |
2 | chr2:78861200-78861800 | Enhancers | Cortex derived primary cultured neurospheres | brain |
3 | chr2:78869000-78869400 | Enhancers | Brain Anterior Caudate | brain |
4 | chr2:78869200-78869800 | Enhancers | Brain Germinal Matrix | brain |
5 | chr2:78869400-78870200 | Enhancers | Colon Smooth Muscle | Colon |